Cytosorbents' Pivotal STAR-T (Safe And Timely Antithrombotic Removal – Ticagrelor) Trial Has Enrolled 80 Patients, Achieving The Second Of Three Key Enrollment Milestones, And Triggering A Pre-specified Data And Safety Monitoring Board Review
Benzinga Newsdesk - Apr 20, 2023, 7:11AM